Targeted Therapies and Personalized Treatment Strategies

Targeted therapies have revolutionized breast cancer treatment by selectively attacking molecular abnormalities while preserving healthy tissues. This track will highlight the latest developments in HER2-targeted therapies, CDK4/6 inhibitors, PARP inhibitors, PI3K inhibitors, endocrine therapy optimization, antibody-drug conjugates, and emerging targeted agents. Discussions will focus on biomarker-guided treatment selection, mechanisms of drug resistance, combination therapies, treatment sequencing, and individualized care pathways. Experts will also examine the integration of precision medicine into clinical practice, enabling clinicians to deliver more effective and less toxic therapies tailored to each patient's unique tumor profile.

    Related Conference of Targeted Therapies and Personalized Treatment Strategies

    July 27-28, 2026

    6th World Congress on Breast Cancer

    Rome, Italy
    August 10-11, 2026

    10th Global Meeting on Oncology and Radiology

    Paris, France
    September 07-08, 2026

    26th World Congress on Cancer and Diagnostics

    Paris, France
    September 28-29, 2026

    36th Experts Meet On Cancer Research & Therapy

    Aix-en-Provence, France
    October 05-06, 2026

    22nd International Conference on Cancer Research

    Madrid, Spain
    November 19-20, 2026

    44th World Cancer Conference

    Dubai, UAE
    November 23-24, 2026

    7th Cancer Diagnostics & Treatment Conference

    Miami, USA
    November 23-24, 2026

    8th International Conference on Women Oncology

    Miami, USA
    November 24-25, 2026

    6th International Conference on Oncology and Cancer

    Paris, France
    December 08-09, 2026

    27th World Congress on Cancer Summit

    Paris, France
    December 08-09, 2026

    14th Euro Breast Cancer and Therapeutics

    Paris, France

    Targeted Therapies and Personalized Treatment Strategies Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in